172 related articles for article (PubMed ID: 38318069)
1. Endothelial downregulation of nuclear m6A reader YTHDC1 promotes pulmonary vascular remodeling in sugen hypoxia model of pulmonary hypertension.
Zheng H; Wu D; Chen X; He W; Hua J; Li Q; Ji Y
Heliyon; 2024 Feb; 10(3):e24963. PubMed ID: 38318069
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the expression of N6-methyladenosine RNA methylation regulators in pulmonary artery hypertension.
Zheng H; Hua J; Li H; He W; Chen X; Ji Y; Li Q
Front Genet; 2022; 13():974740. PubMed ID: 36171892
[No Abstract] [Full Text] [Related]
3. The Effect of N6-Methyladenosine Regulators and m6A Reader YTHDC1-Mediated N6-Methyladenosine Modification Is Involved in Oxidative Stress in Human Aortic Dissection.
Yin F; Liu K; Peng W; Jiang D; Zhang H; Guo P; Wu Y; Zhang X; Sun C; Wang Y; Wang H; Han Y
Oxid Med Cell Longev; 2023; 2023():3918393. PubMed ID: 36819785
[TBL] [Abstract][Full Text] [Related]
4. LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation.
Wang X; Li Q; He S; Bai J; Ma C; Zhang L; Guan X; Yuan H; Li Y; Zhu X; Mei J; Gao F; Zhu D
Mol Med; 2022 Oct; 28(1):126. PubMed ID: 36284300
[TBL] [Abstract][Full Text] [Related]
5. Nuclear m6A reader YTHDC1 promotes muscle stem cell activation/proliferation by regulating mRNA splicing and nuclear export.
Qiao Y; Sun Q; Chen X; He L; Wang D; Su R; Xue Y; Sun H; Wang H
Elife; 2023 Mar; 12():. PubMed ID: 36892464
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia activates GPR146 which participates in pulmonary vascular remodeling by promoting pyroptosis of pulmonary artery endothelial cells.
Jiang Y; Huang J; Xia Y; Sun Z; Hu P; Wang D; Liu Y; Tao T; Liu Y
Eur J Pharmacol; 2023 Feb; 941():175502. PubMed ID: 36638952
[TBL] [Abstract][Full Text] [Related]
7. Low expression of m6A reader YTHDC1 promotes progression of ovarian cancer via PIK3R1/STAT3/GANAB axis.
Wang X; Chen Q; Bing Z; Zhou S; Xu Z; Hou Y; Zhao Y; Zhao S; Wang T
Int J Biol Sci; 2023; 19(14):4672-4688. PubMed ID: 37781028
[No Abstract] [Full Text] [Related]
8. Nanoparticle endothelial delivery of PGC-1α attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling.
Cai D; Chen SY
Redox Biol; 2022 Dec; 58():102524. PubMed ID: 36334380
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of m6A-related diagnostic model for psoriasis.
Liu J; Wang Y; Sheng Y; Cai L; Wang Y
PeerJ; 2024; 12():e17027. PubMed ID: 38436011
[TBL] [Abstract][Full Text] [Related]
10. Identification and verification of IGFBP3 and YTHDC1 as biomarkers associated with immune infiltration and mitophagy in hypertrophic cardiomyopathy.
Li Y; Zhang W; Dai Y; Chen K
Front Genet; 2022; 13():986995. PubMed ID: 36267414
[No Abstract] [Full Text] [Related]
11. The m6A reader YTHDC1-mediated lncRNA CTBP1-AS2 m6A modification accelerates cholangiocarcinoma progression.
Jin Z; Liu Y
Heliyon; 2023 Sep; 9(9):e19816. PubMed ID: 37809459
[TBL] [Abstract][Full Text] [Related]
12. YTHDC1 maintains trophoblasts function by promoting degradation of m6A-modified circMPP1.
Wang D; Guan H; Xia Y
Biochem Pharmacol; 2023 Apr; 210():115456. PubMed ID: 36780989
[TBL] [Abstract][Full Text] [Related]
13. METTL3/YTHDC1-medicated m6A modification of circRNA3634 regulates the proliferation and differentiation of antler chondrocytes by miR-124486-5-MAPK1 axis.
Song M; Yao H; Sun Z; Chen D; Xu X; Long G; Wu L; Hu W
Cell Mol Biol Lett; 2023 Dec; 28(1):101. PubMed ID: 38062349
[TBL] [Abstract][Full Text] [Related]
14. A ring N(CH
Kong S; Yu J; Li HF; Xie YL; Song LF; Wang QQ; Chen YJ; Zhao FR; Zhang WF; Zhu TT
Eur J Pharmacol; 2023 Nov; 959():176077. PubMed ID: 37820784
[TBL] [Abstract][Full Text] [Related]
15. Experimental validation and comprehensive analysis of m6A methylation regulators in intervertebral disc degeneration subpopulation classification.
Xu X; Shen L; Qu Y; Li D; Zhao X; Wei H; Yue S
Sci Rep; 2024 Apr; 14(1):8417. PubMed ID: 38600232
[TBL] [Abstract][Full Text] [Related]
16. YTHDC1 Promotes Stemness Maintenance and Malignant Progression in Head and Neck Squamous Cell Carcinoma.
Weng J; Fan H; Liu H; Tang S; Zheng Y
Stem Cells Int; 2022; 2022():7494354. PubMed ID: 36411870
[TBL] [Abstract][Full Text] [Related]
17. Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension.
Zhang Q; Yaoita N; Tabuchi A; Liu S; Chen SH; Li Q; Hegemann N; Li C; Rodor J; Timm S; Laban H; Finkel T; Stevens T; Alvarez DF; Erfinanda L; de Perrot M; Kucherenko MM; Knosalla C; Ochs M; Dimmeler S; Korff T; Verma S; Baker AH; Kuebler WM
Circulation; 2024 Jun; ():. PubMed ID: 38873770
[TBL] [Abstract][Full Text] [Related]
18. STING Contributes to Pulmonary Hypertension by Targeting the Interferon and BMPR2 Signaling through Regulating F2RL3.
Deng L; Cao C; Cai Z; Wang Z; Leng B; Chen Z; Kong F; Zhou Z; He J; Nie X; Bian JS
Am J Respir Cell Mol Biol; 2024 Jun; ():. PubMed ID: 38864771
[TBL] [Abstract][Full Text] [Related]
19. Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.
Wang Z; Yang K; Zheng Q; Zhang C; Tang H; Babicheva A; Jiang Q; Li M; Chen Y; Carr SG; Wu K; Zhang Q; Balistrieri A; Wang C; Song S; Ayon RJ; Desai AA; Black SM; Garcia JGN; Makino A; Yuan JX; Lu W; Wang J
Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L216-L228. PubMed ID: 30358436
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-specific SIRT7 targeting ameliorates pulmonary hypertension through Krüpple-like factor 4 deacetylation.
Zhang J; Xu C; Tang X; Sun S; Liu S; Yang L; Chen Y; Yang Q; Wei TW; Wu X; Wang J; Wang C; Yan X; Yang L; Niu Y; Gou D; Shyy JYJ; Liu B
Cardiovasc Res; 2024 Mar; 120(4):403-416. PubMed ID: 38198357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
